NEU 3.50% $14.05 neuren pharmaceuticals limited

As per Neuren Announcement 24/4/2024 (Q1 2024 Quarterly...

  1. 236 Posts.
    lightbulb Created with Sketch. 37
    As per Neuren Announcement 24/4/2024 (Q1 2024 Quarterly Report)

    All subject visits completed on schedule in Pitt Hopkins syndrome Phase 2 trial – on track for topline results in Q2 2024

    So Yes GFW you do have your dates wrong - results are imminent !!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.